Detalles de la búsqueda
1.
Diagnostic accuracy and performance of artificial intelligence in measuring left atrial volumes and function on multiphasic CT in patients with atrial fibrillation.
Eur Radiol
; 32(8): 5256-5264, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275258
2.
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.
Oncologist
; 25(1): e160-e169, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31395751
3.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Prostate
; 79(6): 604-613, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663074
4.
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.
Nature
; 477(7362): 99-102, 2011 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21886163
5.
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 148-58, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25260842
6.
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.
Invest New Drugs
; 32(3): 481-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24346280
7.
A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignancies.
Invest New Drugs
; 31(2): 355-62, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22615058
8.
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.
BMC Cancer
; 13: 242, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679351
9.
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.
Invest New Drugs
; 30(2): 714-22, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938715
10.
A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.
Invest New Drugs
; 30(4): 1591-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21863237
11.
MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma.
Cancer Invest
; 30(5): 415-21, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571342
12.
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma.
Mol Ther
; 19(10): 1913-22, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21772252
13.
Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer.
Prostate
; 71(12): 1264-75, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21271613
14.
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
Cancer Chemother Pharmacol
; 87(1): 135-144, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215270
15.
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
BMC Cancer
; 9: 263, 2009 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19643020
16.
An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.
Clin Colorectal Cancer
; 8(1): 29-37, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19203894
17.
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 23(19): 5703-5710, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28655795
18.
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Lung Cancer
; 104: 126-130, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212994
19.
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.
Clin Cancer Res
; 22(10): 2368-76, 2016 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26644411
20.
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
Leuk Lymphoma
; 56(3): 645-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130476